StockData
Cytosorbents Corp logo

Cytosorbents Corp (CTSO) stock

CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 19, 2026Score 2/30
$5.57+1.05 (+23.12%)

Close on Nov 18, 2026Market cap $349.72MP/E –Yield –

Cytosorbents free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Cytosorbents's free cash flow for the twelve months ending Sep 30, 2026 was -$6.99M. For fiscal 2025 it was -$12.54M. The highest annual figure on record is -$2.62M in fiscal 2010.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$12.54M–
FY2024Dec 31, 2024-$14.71M–
FY2023Dec 31, 2023-$22.19M–
FY2022Dec 31, 2022-$34.32M–
FY2021Dec 31, 2021-$17.65M–
FY2020Dec 31, 2020-$6.32M–
FY2019Dec 31, 2019-$17.46M–
FY2018Dec 31, 2018-$11.51M–
FY2017Dec 31, 2017-$7.45M–
FY2016Dec 31, 2016-$6.87M–
FY2015Dec 31, 2015-$9.45M–
FY2014Dec 31, 2014-$6.43M–
FY2013Dec 31, 2013-$3.53M–
FY2012Dec 31, 2012-$3.64M–
FY2011Dec 31, 2011-$3.86M–
FY2010Dec 31, 2010-$2.62M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$287.00K–
Q2 FY2026Jun 30, 2026-$597.00K–
Q1 FY2026Mar 31, 2026-$1.17M–
Q4 FY2025Dec 31, 2025-$4.93M–
Q3 FY2025Sep 30, 2025-$2.59M–
Q2 FY2025Jun 30, 2025-$1.55M–
Q1 FY2025Mar 31, 2025-$3.47M–
Q4 FY2024Dec 31, 2024-$2.41M–
Q3 FY2024Sep 30, 2024-$2.62M–
Q2 FY2024Jun 30, 2024-$4.81M–
Q1 FY2024Mar 31, 2024-$4.87M–
Q4 FY2023Dec 31, 2023-$6.50M–
Q3 FY2023Sep 30, 2023-$5.35M–
Q2 FY2023Jun 30, 2023-$6.72M–
Q1 FY2023Mar 31, 2023-$3.62M–
Q4 FY2022Dec 31, 2022-$5.55M–
Q3 FY2022Sep 30, 2022-$7.37M–
Q2 FY2022Jun 30, 2022-$12.56M–
Q1 FY2022Mar 31, 2022-$8.83M–
Q4 FY2021Dec 31, 2021-$7.02M–
Q3 FY2021Sep 30, 2021-$5.03M–
Q2 FY2021Jun 30, 2021-$2.82M-252.1%
Q1 FY2021Mar 31, 2021-$2.77M–
Q4 FY2020Dec 31, 2020-$1.22M–
Q3 FY2020Sep 30, 2020-$3.51M–
Q2 FY2020Jun 30, 2020$1.86M–
Q1 FY2020Mar 31, 2020-$3.44M–
Q4 FY2019Dec 31, 2019-$4.26M–
Q3 FY2019Sep 30, 2019-$5.33M–
Q2 FY2019Jun 30, 2019-$3.33M–
Q1 FY2019Mar 31, 2019-$4.53M–
Q4 FY2018Dec 31, 2018-$2.88M–
Q3 FY2018Sep 30, 2018-$2.66M–
Q2 FY2018Jun 30, 2018-$3.52M–
Q1 FY2018Mar 31, 2018-$2.45M–
Q4 FY2017Dec 31, 2017-$820.21K–
Q3 FY2017Sep 30, 2017-$2.53M–
Q2 FY2017Jun 30, 2017-$2.04M–
Q1 FY2017Mar 31, 2017-$2.06M–
Q4 FY2016Dec 31, 2016-$1.06M–

More Cytosorbents figures

See a number that looks wrong?